--- title: This Health Startup Helps Coronavirus Patients Take Part in a COVID-19 Clinical Trial - Sanguine description: Brian Neman, CEO and co-founder of Sanguine Biosciences, is bringing the clinical trial into the home. Interview with… image: https://blog.sanguinebio.com/hubfs/Imported_Blog_Media/Startup-Health-1st-option-1-1.jpg --- Mar 30, 2020 1:52:05 PM # This Health Startup Helps Coronavirus Patients Take Part in a COVID-19 Clinical Trial [ Admin ](https://blog.sanguinebio.com/researcher-blog/author/admin) Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial) [Twitter icon ](https://twitter.com/intent/tweet?url=https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial) [envelope icon ](mailto:?body=https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial) # Brian Neman, CEO and co-founder of Sanguine Biosciences, is bringing the clinical trial into the home. *Interview with Logan Plaster, Startup Health* *In our COVID-19 Health Innovation Update series, we’re dropping in on Health Transformers who are tackling the coronavirus. Watch the interview here, on *[*StartUp Health TV*](https://www.youtube.com/user/StartUpHealthTV/videos)*, and scan the key takeaways below.* ##### Key Points - Brian Neman, CEO and co-founder of Sanguine Biosciences, partnered with Vir Biotechnology to complete a COVID-19 clinical study aimed at better understanding the biology of the disease. - Sanguine Biosciences sends nurses and phlebotomists into the homes of recovered COVID-19 patients to collect blood samples. - In an effort to increase safety, Sanguine Biosciences is no longer taking samples from individuals who have been outside the United States in the past 30 days. - “We’re hoping [Vir] can identify the antigens responsible and they can optimize the antibody needed to treat COVID-19,” says Neman. - Anyone who has had COVID-19 and has recovered is invited to take part in this clinical trial. Sign up is at [sanguinebio.com](http://www.sanguinebio.com/). Choose “adult control” or “health control” in the drop down menu. The company is seeking more than 100 subjects currently. - In-home testing for clinical trials has moved from being seen by researchers as a risk, says Neman, to being seen as a risk-mitigation strategy in a post-COVID world.     [COVID-19](https://blog.sanguinebio.com/researcher-blog/tag/covid-19), [Press](https://blog.sanguinebio.com/researcher-blog/tag/press) ## Related posts [![](https://blog.sanguinebio.com/hs-fs/hubfs/Imported_Blog_Media/Biocom-LifeLines-740x440-1.jpg?height=200&name=Biocom-LifeLines-740x440-1.jpg) ](https://blog.sanguinebio.com/researcher-blog/2020/06/21/recovered-patients-help-sanguine-biosciences-advance-covid-19-medical-research) [COVID-19](https://blog.sanguinebio.com/researcher-blog/tag/covid-19), [Press](https://blog.sanguinebio.com/researcher-blog/tag/press) ## [Recovered Patients Help Sanguine BioSciences Advance COVID-19 Medical Research](https://blog.sanguinebio.com/researcher-blog/2020/06/21/recovered-patients-help-sanguine-biosciences-advance-covid-19-medical-research) [Admin](https://blog.sanguinebio.com/researcher-blog/author/admin) Jun 21, 2020 1:29:02 PM Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom LifeLines Magazine [ Read more ](https://blog.sanguinebio.com/researcher-blog/2020/06/21/recovered-patients-help-sanguine-biosciences-advance-covid-19-medical-research) [![](https://blog.sanguinebio.com/hs-fs/hubfs/Imported_Blog_Media/Pharmaceutical-Outsorcing-2nd-Option.jpg?height=200&name=Pharmaceutical-Outsorcing-2nd-Option.jpg) ](https://blog.sanguinebio.com/researcher-blog/2020/06/29/overcoming-study-patient-burdens-in-medical-research-during-the-pandemic) [COVID-19](https://blog.sanguinebio.com/researcher-blog/tag/covid-19), [Press](https://blog.sanguinebio.com/researcher-blog/tag/press) ## [Overcoming Study-Patient Burdens in Medical Research During the Pandemic](https://blog.sanguinebio.com/researcher-blog/2020/06/29/overcoming-study-patient-burdens-in-medical-research-during-the-pandemic) [Admin](https://blog.sanguinebio.com/researcher-blog/author/admin) Jun 29, 2020 9:53:12 AM Written by Brian Neman, Co-Founder & CEO, Sanguine for Pharmaceutical Outsouring [ Read more ](https://blog.sanguinebio.com/researcher-blog/2020/06/29/overcoming-study-patient-burdens-in-medical-research-during-the-pandemic) [![](https://blog.sanguinebio.com/hs-fs/hubfs/Imported_Blog_Media/The-Washington-Post.jpg?height=200&name=The-Washington-Post.jpg) ](https://blog.sanguinebio.com/researcher-blog/2020/05/06/the-urgent-quest-for-a-coronavirus-treatment-involves-door-to-door-blood-collection-and-a-llama-named-winter) [COVID-19](https://blog.sanguinebio.com/researcher-blog/tag/covid-19), [Press](https://blog.sanguinebio.com/researcher-blog/tag/press) ## [The Urgent Quest for a Coronavirus Treatment Involves Door-to-Door Blood Collection and a llama Named Winter](https://blog.sanguinebio.com/researcher-blog/2020/05/06/the-urgent-quest-for-a-coronavirus-treatment-involves-door-to-door-blood-collection-and-a-llama-named-winter) [Admin](https://blog.sanguinebio.com/researcher-blog/author/admin) May 6, 2020 10:41:06 AM Antibody treatments could be a bridge to a vaccine Written by Karin Brulliard and Carolyn Y.... [ Read more ](https://blog.sanguinebio.com/researcher-blog/2020/05/06/the-urgent-quest-for-a-coronavirus-treatment-involves-door-to-door-blood-collection-and-a-llama-named-winter) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Admin", "url" : "https://blog.sanguinebio.com/researcher-blog/author/admin" }, "dateModified" : "2024-08-15T15:14:11.546Z", "datePublished" : "2020-03-30T17:52:05.000Z", "headline" : "This Health Startup Helps Coronavirus Patients Take Part in a COVID-19 Clinical Trial - Sanguine", "image" : [ "https://blog.sanguinebio.com/hubfs/Imported_Blog_Media/Startup-Health-1st-option-1-1.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.sanguinebio.com/researcher-blog/2020/03/30/this-health-startup-helps-coronavirus-patients-take-part-in-a-covid-19-clinical-trial", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.sanguinebio.com/hubfs/Sanguine%20Logo.png" }, "name" : "Sanguine Biosciences, Inc." } } ```